
Hamdan names 3 new DHA CEOs as Dubai resets health regulation and digital health leadership
Dubai has named new DHA CEOs for regulation, digital health and corporate support. Clinics, insurers and patients should watch execution.
How Zavis verifies this coverage
Editorial standards, source rules, methodology, and review provenance are public.
Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum has appointed three new CEOs at the Dubai Health Authority (DHA), putting new named leaders over health regulation, digital health and corporate support in Dubai.
The appointments matter most to COOs, CIOs and CEOs of Dubai healthcare operators. The decision does not announce a new tariff, licence fee or inspection deadline. It does identify the people now responsible for the DHA functions that affect facility licensing, professional licensing, health data exchange, insurer workflows and service delivery for patients.
What changed at DHA
According to Emirates 24|7, Sheikh Hamdan issued Executive Council Resolution No. 52 of 2026 appointing Asma Abdullah Saad Al Sherif as CEO of the Health Regulatory Sector at DHA. The same report said Executive Council Resolution No. 53 of 2026 appointed Majid Sultan Al Muhairi as CEO of the Digital Health Sector, while Executive Council Resolution No. 54 of 2026 appointed Mona Mohammad Bajman Almarzooqi as CEO of the Corporate Support Sector.
The resolutions are effective from their date of issuance and will be published in the Official Gazette. Emirates 24|7 published the story on 8 September 2026. For licensed providers, the practical point is timing. Any change in forms, service-level targets, audit practices or data requirements will usually appear later through DHA circulars, the Sheryan portal or Official Gazette publication.
The first portfolio is the one clinic owners will watch most closely. DHA's Sheryan portal is the channel for healthcare professionals, healthcare facilities and the Dubai Medical Registry. A change in regulatory leadership can affect how quickly applications move, how inspections are sequenced and how licence renewals are interpreted.
Why clinics and insurers should care
Dubai operators should treat the appointment of a CEO for the Health Regulatory Sector as a governance signal, rather than a rule change. The checklist for the next 30 to 90 days is basic: monitor DHA circulars, check pending Sheryan transactions, review expiring professional licences and confirm whether open facility approvals have named case owners.
- COOs should map every active DHA application, inspection and licence renewal to an internal owner by 30 September 2026.
- CIOs should confirm which EMR, claims and patient identity systems depend on DHA digital-health requirements.
- CFOs should separate confirmed DHA fees from consultant estimates before changing 2027 budgets.
- Insurers such as Sukoon should watch for changes that affect provider onboarding, claims data fields or network verification.
The digital-health appointment is the second operational signal. DHA's NABIDH programme has already connected more than 9.47 million patient records and more than 1,300 healthcare facilities, according to a 4 November 2024 Emirates News Agency report. That makes the Digital Health Sector relevant to hospitals, clinics, laboratories, pharmacies, EMR vendors and revenue-cycle teams.
For insurers, the immediate question is whether DHA's digital-health leadership will move faster on data quality, claims interoperability or provider registry consistency. Dubai's decisions may also matter in Abu Dhabi, where the Department of Health Abu Dhabi (DOH Abu Dhabi) regulates providers and where Daman and Thiqa sit closer to government-funded coverage. In the northern emirates, the Ministry of Health and Prevention (MOHAP) remains the relevant regulator for licensing and facility oversight.
What operators should watch next
The appointment of a Corporate Support Sector CEO is less visible to patients, but it can affect procurement, internal service delivery, call-centre performance and how fast DHA systems respond to providers. For a clinic group, a one-week delay in a licence activation can mean postponed opening revenue, idle staff and rescheduled patients. Operators should track turnaround times by transaction type, rather than relying on anecdotal delays.
Patients will see the effect only if the leadership changes shorten approval cycles, improve registry accuracy or reduce friction in data exchange. A patient comparing Dubai providers should still verify three items before booking: the facility licence, the doctor's active professional status and the insurer network status for the specific plan.
The next hard evidence will be in the Official Gazette text, DHA circulars and Sheryan service changes after 8 September 2026. Until then, the appointment is a management change with regulatory and digital-health consequences, rather than a compliance mandate.
For provider checks, readers can use the UAE Open Healthcare Directory, which lists 12,387+ licensed healthcare providers across the UAE and links searches to DHA, DOH Abu Dhabi and MOHAP-regulated markets.
Zavis Intelligence
Healthcare Industry Desk
Contributing to UAE healthcare industry coverage
Related coverage
FAQ
What is happening in UAE healthcare industry?
Dubai has named new DHA CEOs for regulation, digital health and corporate support. Clinics, insurers and patients should watch execution.



